Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-11

Clinical Trial Update: Effect of Acetylcholinesterase Inhibitors on Bone Metabolism [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the effect of acetylcholinesterase inhibitors on bone metabolism in osteoporosis; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Duke University | Conditions: Osteoporosis | Phase 2 | Status: RECRUITING